Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Generative Artificial Intelligence on Diagnosing Rheumatoid Arthritis Complications

NCT07301892 is registered in ClinicalTrials.gov with Guang'anmen Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT07301892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07301892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Generative Artificial Intelligence on Diagnosing Rheumatoid Arthritis Complications
Lead sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2025
Completion date
June 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, cardiovascular diseases, interstitial lung disease, liver disorders, osteoarthritis, osteoporosis, peripheral neuropathy, pulmonary complications, ra complications, renal lesions, rheumatoid arthritis (ra, sjogren's syndrome, thrombosis, thyroid diseases, vasculitis